Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine | Fortune

Drugmakers found apromising curefor the obesity epidemic and their stocks were rewarded for it. Now, investors…

Russia is teaching its children to fight the wars of the future | Fortune

Students returning to Russian schools next week will discover a change to their civics courses that…

Wall Street Isn't Giving Up on CVS Health — and Its Valuation Looks Stronger Than Investors Think |

CVS Health (CVS +3.93%) is a vertically integrated healthcare giant. It has around 9,000 retail pharmacy…

Robinhood and Interactive Brokers Both Ride Retail Volume. Only One Earns on Idle Cash. |

CBOE Global Markets (CBOE +1.96%) reported record revenues in the second quarter of 2026, up 25%…

President Trump Says the CFTC Is Working to Bring Hyperliquid to the United States. Does That Make It a Screaming Buy? |

Hyperliquid (HYPE +3.78%) soared by 11% on Aug. 19 after President Donald Trump mentioned it by…

If You'd Invested $1,000 in QQQ 20 Years Ago, Here's What You'd Have Today |

Twenty years ago, investing $1,000 in stocks might not have seemed like enough to make a…

Amazon.com vs. MercadoLibre: A Look at Which E-Commerce Stock Is a Better Investment in 2026 |

Choosing between a global titan and a regional powerhouse can define a portfolio. Amazon.com (AMZN -1.83%)…

Peter Thiel's Fund Reported Zero Stocks for 2 Straight Quarters. Its $419 Million Comeback Put 72% Into Energy and Power. |

Peter Thiel’s hedge fund disappeared from the stock market for six months. Thiel Macro, the firm…

3 Things That Matter Most for Eli Lilly Now |

Eli Lilly (LLY -0.13%) is a market darling, given its success in the GLP-1 weight-loss space.…

Bitcoin Could Hit $300,000 by 2030, Says Coinbase CEO Brian Armstrong. Here's Why He's Right. |

Bitcoin (BTC +0.65%) rose 25% in August. That’s making a lot of investors giddy about where…

zh_CNChinese